Home/ Supplements/ Berberine/ Berberine Phytosome

Berberine Phytosome

product on market Capsule Enzymedica Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Berberine Phytosome
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Berbevis
275 mg

Other Ingredients

Rice Husk Rice Bran Extract Cellulose Water
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended use: 1 capsule before meals with a glass of water, twice a day.

Warnings & Precautions

Consult with a physician prior to use if you are pregnant or nursing, taking medications or have a medical condition.

Caution: This product is not intended for individuals with impaired glucose metabolism such as prediabetes or diabetes. Do not use if safety seal is broken or missing.

Please keep out of reach of children

Formulation Notes

For healthy blood sugar metabolism

Vegan Dietary Supplement

Ultra absorption phytosome technology

The human body has difficulty absorbing berberine to unlock its true benefits. Berbevis phytosome solves this problem, boosting bioavailability 9.6x compared to standard raw extracts. This unlocks greater potency at a lower dose, allowing for a small, easy-to-swallow capsule. 9.6x better bioavailability than standard berberine

Contains no: Milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, sesame, or artificial colors and flavors. No fillers added

Made in USA with global ingredients

Additional Information

Keep closed in dry place; avoid excessive heat.

A pharmacokinetic study shows Berbevis improved berberine bioavailability (AUC) by ~ 10 times on a molar basis and with observed dose linearity.

Metadata

Product Details

DSLD Entry Date2025-05-21
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID328874
Data Updated2026-04-11
Research

Research Evidence

98
Research Sources
55
Avg Quality
48
Systematic Review
39
Meta Analysis
4
Rct
4
Clinical Trial
1
Other
1
Narrative Review
1
Openfda Safety
B Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2018 PubMed DOI
B Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Clinical nutrition ESPEN 2022 PubMed DOI
B Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 PubMed DOI
B Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
B Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta Analysis The Journal of nutrition 2023 PubMed DOI
B The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Meta Analysis Journal of translational medicine 2024 PubMed DOI
B Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Systematic Review International journal of molecular sciences 2024 PubMed DOI
B Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis The American journal of Chinese medicine 2019 PubMed DOI
B Effects of Berries, Phytochemicals, and Probiotics on Atherosclerosis through Gut Microbiota Modification: A Meta-Analysis of Animal Studies
Meta Analysis International journal of molecular sciences 2023 PubMed DOI
B Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
Rct JAMA network open 2025 PubMed DOI
View all evidence for Berberine →
Compare

Similar Products

View all Berberine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.